TH-Z827
TH-Z827 is a mutant-selective small molecule inhibitor targeting KRAS (G12D) with an IC50 of 2.4 μM, showing no activity against KRAS (WT) or KRAS (G12C) . It also disrupts the KRAS (G12D) -CRAF interaction (IC50 = 42 μM) . This compound is a valuable research tool for investigating mutant-specific KRAS signaling in cancer cell-based and biochemical assays.
Product Specifications
CAS Number
2847881-81-4
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
O (C[C@H]1N (C) CCC1) C2=NC (=C3C (CN (CC3) C=4C5=C (C=CC4) C=CC=C5C) =N2) N6C7CCC6CNC7
Molecular Formula
C30H38N6O
Molecular Weight
498.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6288930-01 0.1 mL
CRMP1, NT (CRMP1, DPYSL1, ULIP3, Dihydropyrimidinase-related protein 1, Collapsin response mediator protein 1, Unc-33-like phosphoprotein 3) (MaxLight 550)
Sign In for Pricing
View Details 
MBS6288930-02 5x 0.1 mL
CRMP1, NT (CRMP1, DPYSL1, ULIP3, Dihydropyrimidinase-related protein 1, Collapsin response mediator protein 1, Unc-33-like phosphoprotein 3) (MaxLight 550)
Sign In for Pricing
View Details 
K1237207 1.0 µg DNA
LRRC57 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details RC203805L3V 200 µL
Papillary renal cell carcinoma (PRCC) (NM_005973) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details MBS2056349-01 0.1 mL
APC-Linked Polyclonal Antibody to Mannose Receptor C Type 1 (MRC1)
Sign In for Pricing
View Details